Abstract
Fluoro-18-deoxyglucose positron emission tomography computed tomography (FDG-PET/CT) and magnetic resonance imaging (MRI), including unenhanced single-shot spin-echo echo planar imaging (SS SE-EPI) and small paramagnetic iron oxide (SPIO) enhancement, were compared prospectively for detecting colorectal liver metastases. Twenty-four consecutive patients suspected for metastases underwent MRI and FDG-PET/CT. Fourteen patients (58%) had previously received chemotherapy, including seven patients whose chemotherapy was still continuing to within 1 month of the PET/CT study. The mean interval between PET/CT and MRI was 10.2 ± 5.2 days. Histopathology (n = 18) or follow-up imaging (n = 6) were used as reference. Seventy-seven metastases were detected. In nine patients, MRI and PET/CT gave concordant results. Sensitivities for unenhanced SS SE-EPI, MRI without SS SE-EPI and FDG-PET/CT were, respectively, 100% (p = 9 × 10−10 vs PET, p = 8 × 10−3 vs MRI without SS SE-EPI), 90% (p = 2 × 10−7 vs PET) and 60%. PET/CT sensitivity dropped significantly with decreasing size, from 100% in lesions larger than 20 mm (identical to MRI), over 54% in lesions between 10 and 20 mm (p = 3 × 105 versus unenhanced SS SE-EPI), to 32% in lesions under 10 mm (p = 6 × 10−5 versus unenhanced SS SE-EPI). Positive predictive value of PET was 100% (identical to MRI). MRI, particularly unenhanced SS SE-EPI, has good sensitivity and positive predictive value for detecting liver metastases from colorectal carcinoma. Its sensitivity is better than that of FDG-PET/CT, especially for small lesions.
Similar content being viewed by others
References
Ward J (2006) New MR techniques for the detection of liver metastases. Cancer Imaging 6:33–42
Kinkel K, Lu Y, Both M et al (2002) Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR Imaging, PET): a meta-analysis. Radiology 224:748–756
Semelka R, Martin D, Balci C et al (2001) Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging 13:397–401
Martin D, Semelka R (2001) Imaging of benign and malignant focal liver lesions. Magn Reson Imaging Clin N Am 9:785–802
Rappeport E, Loft A, Berthelsen A et al (2007) Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDGPET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation. Acta Radiol 48:369–378
Coenegrachts K, Orlent H, ter Beek L et al (2008) Improved focal liver lesion detection: comparison of single-shot spin-echo echo-planar and superparamagnetic iron oxide (SPIO)-enhanced MRI. J Magn Reson Imaging 27:117–124
Boykin K, Zibari G, Lilien D et al (1999) The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver. Am J Surg 65:1183–1185
Delbeke D, Vitola J, Sandler M et al (1997) Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med 38:1196–1201
Zhuang H, Sinha P, Pourdehnad M et al (2000) The role of positron emission tomography with fluorine-18-deoxyglucose in identifying colorectal cancer metastases to liver. Nucl Med Commun 21:793–797
Bipat S, van Leeuwen M, Comans E et al (2005) Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-metaanalysis. Radiology 237:123–131
Cascini G, Avallone A, Delrio P et al (2006) 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. J Nucl Med 47:1241–1248
Mawlawi O, Podoloff D, Kohlmyer S (2004) Performance characteristics of a newly developed PET/CT scanner using NEMA standards in 2D and 3D modes. J Nucl Med 45:1734–1742
Kehagias D, Gouliamos A, Smyrniotis V et al (2001) Diagnostic efficacy and safety of MRI of the liver with superparamagnetic iron oxide particles (SH U 555 A). J Magn Reson Imaging 14:595–601
Kim J, Kim M, Suh S et al (2002) Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times. J Magn Reson Imaging 15:573–583
Grangier C, Tourniaire J, Mentha G et al (1994) Enhancement of liver hemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles. J Comput Assist Tomogr 18:888–896
Denys A, Arrive L, Servois V et al (1994) Hepatic tumors: Detection and characterization at 1-T MR imaging enhanced with AMI-25. Radiology 193:665–669
Seneterre E, Taourel P, Bouvier Y et al (1996) Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 200:785–792
Ward J, Naik K, Guthrie J et al (1999) Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Radiology 210:459–466
Oudkerk M, van den Heuvel A, Wielopolski P et al (1997) Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging. Radiology 203:449–456
Akhurst T, Kates T, Mazumdar M et al (2005) Recent chemotherapy reduces the sensitivity of [18F] fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases. J Clin Oncol 23:8713–8716
Bohm B, Voth M, Geoghegan J et al (2004) Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors. J Cancer Res Clin Oncol 130:266–272
Fong Y, Saldinger P, Akhurst T et al (1999) Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg 178:282–287
Imdahl A, Reinhardt M, Nitzsche E et al (2000) Impact of 18F-FDG positron emission tomography for decision making in colorectal cancer recurrences. Arch Surg 385:129–134
Lai D, Fulham M, Stephen M et al (1996) The role of wholebody positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. Arch Surg 131:703–707
Rohren E, Paulson E, Hagge R et al (2002) The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases from colorectal cancer. Clin Nucl Med 27:550–555
Ruers T, Langenhoff B, Neeleman N et al (2002) Value of positron emission tomography with [F-18] fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J Clin Oncol 20:388–395
Rydzewski B, Dehdashti F, Gordon B et al (2002) Usefulness of intraoperative sonography for revealing hepatic metastases from colorectal cancer in patients selected for surgery after undergoing FDG PET. AJR Am J Roentgenol 178:353–358
Truant S, Huglo D, Hebbar M et al (2005) Prospective evaluation of the impact of [18F]fluoro-2-deoxyglucose positron emission tomography of respectable colorectal liver metastases. Br J Surg 92:362–369
Vitola J, Delbeke D, Sandler M et al (1996) Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg 171:21–26
Sahani D, Kalva S, Fischman A et al (2005) Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET. AJR Am J Roentgenol 185:239–246
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Coenegrachts, K., De Geeter, F., ter Beek, L. et al. Comparison of MRI (including SS SE-EPI and SPIO-enhanced MRI) and FDG-PET/CT for the detection of colorectal liver metastases. Eur Radiol 19, 370–379 (2009). https://doi.org/10.1007/s00330-008-1163-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-008-1163-y